Evaluation of the Sofia SARS Antigen FIA Assay for COVID-19
NCT04953091 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-07-12
Summary
Evaluating the performance of the Sofia SARS Antigen FIA
Conditions
- SARS-CoV2 Infection
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-12
- Primary Completion
- 2021-07-31
- Completion
- 2021-07-31
Countries
- France
Study Locations
More Related Trials
-
Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System
NCT04860895 ·Status: UNKNOWN ·Phase: NA
-
SARS-CoV-2 Infection Among Healthcare Workers
NCT05680896 ·Status: UNKNOWN
-
Strep A FIA Field Study, Sofia
NCT02153008 ·Status: COMPLETED
-
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522 ·Status: UNKNOWN
-
Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition.
NCT06057025 ·Status: UNKNOWN ·Phase: PHASE3
-
PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19)
NCT04613310 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00846105 ·Status: COMPLETED ·Phase: NA
-
COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)
NCT04625257 ·Status: RECRUITING
-
Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil
NCT01359358 ·Status: UNKNOWN
-
Evaluation of the Efficacy and Safety of Nano-S1
NCT05822180 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 STAndard of Care in Sub-Saharan Africa
NCT04885543 ·Status: COMPLETED
-
Evaluation of Antibody Tests for COVID-19
NCT04360954 ·Status: COMPLETED
-
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
NCT04659941 ·Status: UNKNOWN ·Phase: PHASE2
-
Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2
NCT04611841 ·Status: UNKNOWN
-
Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections
NCT03833102 ·Status: COMPLETED
-
Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations
NCT05664919 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
NCT05716425 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response and Risk of Serious Infection to SARS-Cov2
NCT04410432 ·Status: COMPLETED
-
Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)
NCT05244330 ·Status: COMPLETED
-
Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)
NCT04479488 ·Status: COMPLETED
-
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
NCT04885452 ·Status: COMPLETED
-
Feasibility and Usability of COVID-19 Antigen RDTs in Uganda
NCT05630300 ·Status: COMPLETED ·Phase: NA
-
COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2
NCT04318314 ·Status: UNKNOWN
-
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)
NCT05506618 ·Status: UNKNOWN ·Phase: NA
-
Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites
NCT05769803 ·Status: UNKNOWN ·Phase: NA